NCT01910311View on ClinicalTrials.gov

A Study of Baricitinib and Rifampicin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Baricitinib

Administered orally

DRUG

Rifampicin

Administered orally

Trial Locations (1)

LS2 9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01910311 - A Study of Baricitinib and Rifampicin in Healthy Participants | Biotech Hunter | Biotech Hunter